United States Recombinant Human Insulin Market Report 2017

February 2017 | 122 pages | ID: U4C2D784AE1EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Recombinant Human Insulin

Revenue, means the sales value of Recombinant Human Insulin

This report studies sales (consumption) of Recombinant Human Insulin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novo Nordisk
• Eli Lilly
• Bioton
• Dongbao
• United Laboratories (TUL)

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of Recombinant Human Insulin in each application, can be divided into

• Application 1
• Application 2

Contents

United States Recombinant Human Insulin Market Report 2017

1 RECOMBINANT HUMAN INSULIN OVERVIEW

1.1 Product Overview and Scope of Recombinant Human Insulin
1.2 Classification of Recombinant Human Insulin
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Recombinant Human Insulin
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Recombinant Human Insulin (2012-2022)
  1.4.1 United States Recombinant Human Insulin Sales and Growth Rate (2012-2022)
  1.4.2 United States Recombinant Human Insulin Revenue and Growth Rate (2012-2022)

2 UNITED STATES RECOMBINANT HUMAN INSULIN COMPETITION BY MANUFACTURERS

2.1 United States Recombinant Human Insulin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Recombinant Human Insulin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Recombinant Human Insulin Average Price by Manufactures (2015 and 2016)
2.4 Recombinant Human Insulin Market Competitive Situation and Trends
  2.4.1 Recombinant Human Insulin Market Concentration Rate
  2.4.2 Recombinant Human Insulin Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES RECOMBINANT HUMAN INSULIN SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Recombinant Human Insulin Sales and Market Share by States (2012-2017)
3.2 United States Recombinant Human Insulin Revenue and Market Share by States (2012-2017)
3.3 United States Recombinant Human Insulin Price by States (2012-2017)

4 UNITED STATES RECOMBINANT HUMAN INSULIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Recombinant Human Insulin Sales and Market Share by Type (2012-2017)
4.2 United States Recombinant Human Insulin Revenue and Market Share by Type (2012-2017)
4.3 United States Recombinant Human Insulin Price by Type (2012-2017)
4.4 United States Recombinant Human Insulin Sales Growth Rate by Type (2012-2017)

5 UNITED STATES RECOMBINANT HUMAN INSULIN SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Recombinant Human Insulin Sales and Market Share by Application (2012-2017)
5.2 United States Recombinant Human Insulin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES RECOMBINANT HUMAN INSULIN MANUFACTURERS PROFILES/ANALYSIS

6.1 Novo Nordisk
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Recombinant Human Insulin Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novo Nordisk Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Eli Lilly
  6.2.2 Recombinant Human Insulin Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Eli Lilly Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bioton
  6.3.2 Recombinant Human Insulin Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bioton Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Dongbao
  6.4.2 Recombinant Human Insulin Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Dongbao Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 United Laboratories (TUL)
  6.5.2 Recombinant Human Insulin Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 United Laboratories (TUL) Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 RECOMBINANT HUMAN INSULIN MANUFACTURING COST ANALYSIS

7.1 Recombinant Human Insulin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Human Insulin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Recombinant Human Insulin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Human Insulin Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES RECOMBINANT HUMAN INSULIN MARKET FORECAST (2017-2022)

11.1 United States Recombinant Human Insulin Sales, Revenue Forecast (2017-2022)
11.2 United States Recombinant Human Insulin Sales Forecast by Type (2017-2022)
11.3 United States Recombinant Human Insulin Sales Forecast by Application (2017-2022)
11.4 Recombinant Human Insulin Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Human Insulin
Table Classification of Recombinant Human Insulin
Figure United States Sales Market Share of Recombinant Human Insulin by Type in 2015
Table Application of Recombinant Human Insulin
Figure United States Sales Market Share of Recombinant Human Insulin by Application in 2015
Figure United States Recombinant Human Insulin Sales and Growth Rate (2012-2022)
Figure United States Recombinant Human Insulin Revenue and Growth Rate (2012-2022)
Table United States Recombinant Human Insulin Sales of Key Manufacturers (2015 and 2016)
Table United States Recombinant Human Insulin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Human Insulin Sales Share by Manufacturers
Figure 2016 Recombinant Human Insulin Sales Share by Manufacturers
Table United States Recombinant Human Insulin Revenue by Manufacturers (2015 and 2016)
Table United States Recombinant Human Insulin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Recombinant Human Insulin Revenue Share by Manufacturers
Table 2016 United States Recombinant Human Insulin Revenue Share by Manufacturers
Table United States Market Recombinant Human Insulin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Recombinant Human Insulin Average Price of Key Manufacturers in 2015
Figure Recombinant Human Insulin Market Share of Top 3 Manufacturers
Figure Recombinant Human Insulin Market Share of Top 5 Manufacturers
Table United States Recombinant Human Insulin Sales by States (2012-2017)
Table United States Recombinant Human Insulin Sales Share by States (2012-2017)
Figure United States Recombinant Human Insulin Sales Market Share by States in 2015
Table United States Recombinant Human Insulin Revenue and Market Share by States (2012-2017)
Table United States Recombinant Human Insulin Revenue Share by States (2012-2017)
Figure Revenue Market Share of Recombinant Human Insulin by States (2012-2017)
Table United States Recombinant Human Insulin Price by States (2012-2017)
Table United States Recombinant Human Insulin Sales by Type (2012-2017)
Table United States Recombinant Human Insulin Sales Share by Type (2012-2017)
Figure United States Recombinant Human Insulin Sales Market Share by Type in 2015
Table United States Recombinant Human Insulin Revenue and Market Share by Type (2012-2017)
Table United States Recombinant Human Insulin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Human Insulin by Type (2012-2017)
Table United States Recombinant Human Insulin Price by Type (2012-2017)
Figure United States Recombinant Human Insulin Sales Growth Rate by Type (2012-2017)
Table United States Recombinant Human Insulin Sales by Application (2012-2017)
Table United States Recombinant Human Insulin Sales Market Share by Application (2012-2017)
Figure United States Recombinant Human Insulin Sales Market Share by Application in 2015
Table United States Recombinant Human Insulin Sales Growth Rate by Application (2012-2017)
Figure United States Recombinant Human Insulin Sales Growth Rate by Application (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Recombinant Human Insulin Sales Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Recombinant Human Insulin Sales Market Share (2012-2017)
Table Bioton Basic Information List
Table Bioton Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bioton Recombinant Human Insulin Sales Market Share (2012-2017)
Table Dongbao Basic Information List
Table Dongbao Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Dongbao Recombinant Human Insulin Sales Market Share (2012-2017)
Table United Laboratories (TUL) Basic Information List
Table United Laboratories (TUL) Recombinant Human Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
Table United Laboratories (TUL) Recombinant Human Insulin Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Human Insulin
Figure Manufacturing Process Analysis of Recombinant Human Insulin
Figure Recombinant Human Insulin Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Human Insulin Major Manufacturers in 2015
Table Major Buyers of Recombinant Human Insulin
Table Distributors/Traders List
Figure United States Recombinant Human Insulin Production and Growth Rate Forecast (2017-2022)
Figure United States Recombinant Human Insulin Revenue and Growth Rate Forecast (2017-2022)
Table United States Recombinant Human Insulin Production Forecast by Type (2017-2022)
Table United States Recombinant Human Insulin Consumption Forecast by Application (2017-2022)
Table United States Recombinant Human Insulin Sales Forecast by States (2017-2022)
Table United States Recombinant Human Insulin Sales Share Forecast by States (2017-2022)